TLDR
- Shares of HIMS declined 0.91% to close at $30.64 on Monday despite nationwide Hers platform debut.
- Company rolls out comprehensive women’s health services covering weight loss, hair restoration, and menopause.
- Australian market entry finalized through integration of previously acquired Eucalyptus brand.
- Platform delivers personalized treatment plans with 24/7 practitioner access for female patients.
- Telehealth sector in Australia projected to surge, creating significant growth runway.
Shares of Hims & Hers Health (HIMS) closed down 0.91% at $30.64 on Monday, even as the telehealth provider rolled out its Hers women’s healthcare platform across Australia. The stock shed $0.28 throughout the trading day and continued sliding in extended hours, dropping another 0.13% to reach $30.60. The decline came despite the company completing a significant international milestone with nationwide service availability for Australian women.
Hims & Hers Health, Inc., HIMS
Company Rolls Out Comprehensive Women’s Health Platform Across Australian Market
On October 12, Hims & Hers officially unveiled the Hers platform throughout Australia, marking a major step in its global healthcare footprint. The digital service delivers treatment options spanning weight management, hair restoration, menopause care, and perimenopause support via virtual consultations. Australian women now have access to licensed healthcare providers, prescription medication delivery, and a support team operating 24 hours daily.
The nationwide rollout represents the culmination of the company’s Eucalyptus acquisition completed earlier in 2024, bolstering its Australian digital health presence. As part of the transition strategy, Eucalyptus’ women’s health division Juniper has been rebranded under the Hers name. The company previously converted its Pilot men’s health service to the Hims brand in August, completing the unified brand architecture across the continent.
The service portfolio includes integrated weight management solutions combining pharmaceutical interventions with dietary counseling and exercise programming. Additionally, Hers delivers hair loss therapies and hormonal health management addressing various life stages. Patients can specifically request female medical practitioners and participate in an online community comprising more than 27,000 Australian women.
Digital Platform Addresses Healthcare Accessibility Barriers for Women
The Hers launch specifically targets persistent gaps in women’s healthcare access throughout Australia’s urban and remote regions. Company research revealed that 52% of Australian women surveyed experienced weight-based discrimination from medical professionals. Of those respondents, 72% subsequently delayed or avoided seeking necessary medical care, demonstrating significant treatment barriers.
The research also pinpointed financial constraints and distance challenges as major impediments to specialized healthcare services. Approximately 30% of Australia’s population resides in rural and regional areas, where specialist appointments often involve lengthy wait times. Hers seeks to bridge these gaps by facilitating virtual appointments with qualified practitioners and providing ongoing digital care coordination.
Rebecca Holdt, who serves as international product vice president, stressed the importance of digital platforms in democratizing healthcare delivery nationwide. Australian Chief Medical Officer Matt Vickers underscored the necessity for evidence-driven services meeting women’s comprehensive health needs. Existing Juniper customers will maintain continuity with their current Australian healthcare providers while accessing expanded treatment categories.
International Footprint Grows as Company Enters Expanding Telehealth Market
The Australian deployment expands Hims & Hers’ global operations beyond its established markets in North America and Europe. The company enters a rapidly developing telehealth ecosystem experiencing heightened demand for convenient digital healthcare solutions. Market forecasts referenced by the organization suggest Australia’s telehealth industry could achieve $2.56 billion in value by 2034.
Gus Wood assumes responsibility for Australian operations as general manager, working alongside Chief Medical Officer Matt Vickers. Jessica Shepherd, serving as Hers Chief Medical Officer, will provide clinical governance ensuring alignment with the company’s global healthcare protocols. This management framework merges local medical knowledge with the organization’s established technology platform and treatment methodology.
Despite the strategic expansion announcement, Hims & Hers Health shares concluded Monday’s trading session in negative territory and continued declining after hours. The latest platform launch diversifies the company’s service catalog beyond current offerings and creates a cohesive brand identity throughout Australia. Nevertheless, the stock’s downward movement Monday stood in contrast to the company’s aggressive push into international digital healthcare territories.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
